High-fat and high-carbohydrate diets increase bone fragility through TGF-β–dependent control of osteocyte function
DOE
Questions this answers
Sources
- doe_osti · checked 2024-08-22
Source record
The underlying research record — supporting evidence for the object above.
Key Details
- Posted Date
- Source
- doe_osti
Description
Obesity can increase the risk of bone fragility, even when bone mass is intact. This fragility stems from poor bone quality, potentially caused by deficiencies in bone matrix material properties. However, cellular and molecular mechanisms leading to obesity-related bone fragility are not fully understood. Using male mouse models of obesity, we discovered TGF-β signaling plays a critical role in mediating the effects of obesity on bone. High-carbohydrate and high-fat diets increase TGF-β signaling in osteocytes, which impairs their mitochondrial function, increases cellular senescence, and compromises perilacunar/canalicular remodeling and bone quality. By specifically inhibiting TGF-β signaling in mouse osteocytes, some of the negative effects of high-fat and high-carbohydrate diets on bones, including the lacunocanalicular network, perilacunar/canalicular remodeling, senescence, and mechanical properties such as yield stress, were mitigated. DMP1-Cre–mediated deletion of TGF-β receptor II also blunted adverse effects of high-fat and high-carbohydrate diets on energy balance and metabolism. These findings suggest osteocytes are key in controlling bone quality in response to high-fat and high-carbohydrate diets. Calibrating osteocyte function could mitigate bone fragility associated with metabolic diseases while reestablishing energy balance.. Authors: Dole, Neha S. [University of California, San Francisco, CA (United States); University of Arkansas for Medical Sciences, Little Rock, AR (United States)]; Betancourt-Torres, Andrés [University of California, San Francisco, CA (United States)]; Kaya, Serra [University of California, San Francisco, CA (United States)]; Obata, Yoshihiro [University of Utah, Salt Lake City, UT (United States)]; Schurman, Charles A. [University of California, San Francisco, CA (United States); University of California Berkeley, San Francisco, CA (United States)]. DOE Contract: AC02-05CH11231. Subjects: 59 BASIC BIOLOGICAL SCIENCES; Research & Experimental Medicine